Logo image
Snake venom proteases as potential cancer therapeutics
圖書章節

Snake venom proteases as potential cancer therapeutics

Ho Phin Chong 和 Choo Hock Tan
Therapeutics of Natural and Synthetic Compounds in Protease-Induced Cancer, 頁碼.603-622
01/01/2025

摘要

cancer Drug development metalloproteinase serine protease snake venom tumor
Snake venoms are a rich and diverse source of pharmacologically active compounds with immense potential in biomedical applications, including drug discovery. In cancer research, the bioactive molecules in snake venom—particularly snake venom metalloproteinases (SVMPs) and snake venom serine proteases (SVSPs)—have emerged as potential agents for cancer therapy. SVMPs, which are known to target extracellular matrix components and integrins, can disrupt tumor microenvironments and inhibit cancer cell adhesion, migration, and angiogenesis, making them potent anticancer agents. These metalloproteinases also activate intrinsic and extrinsic pathways that lead to apoptosis and tumor suppression. SVSPs exhibit unique anticancer properties by inhibiting tumor cell proliferation, inducing cell death, and preventing metastasis. Together, these venom-derived proteases offer promising avenues for novel cancer treatments due to their ability to target key molecular pathways involved in tumor progression. In drug design, these molecules can serve as templates for novel cancer therapies with minimized adverse effects and the ability to overcome resistance. This chapter provides an overview of recent development in this topic, and concludes with a forward-looking discussion on the future need for more in-depth research to unleash the potential of these proteins as targeted cancer treatment.

檔案與連結 (1)

url
https://doi.org/10.1016/B978-0-443-26635-5.00037-7檢視

相關連結

指標

1 檢視次數

聯合國永續發展目標(SDGs)

此研究成果有助於達成以下目標:

#3 Good Health and Well-Being

來源:SDGs的產出

詳細資料

Logo image